Cynosure Signs Exclusive Distribution Agreement With Depilite Medic Spa in Mexico, Argentina, Colombia, Honduras and Peru
March 13 2007 - 9:30AM
PR Newswire (US)
Company Broadens International Reach of Affirm(TM) Anti-Aging and
Elite(TM) Hair-Removal Technology to Five New Markets WESTFORD,
Mass., March 13 /PRNewswire-FirstCall/ -- Cynosure, Inc.
(NASDAQ:CYNO), a leading developer and manufacturer of a broad
array of light-based aesthetic treatment systems, today announced
the signing of an agreement with Depilite Medic Spa Equipment
Corp., under which Depilite will be the exclusive distributor of
Cynosure's Affirm(TM) and Apogee Elite(TM) workstations in Mexico,
Argentina, Colombia, Honduras and Peru. Depilite currently operates
more than 100 branches located in seven countries in North America,
Europe and Latin America. Cynosure's Affirm workstation is the
Company's solution for anti-aging applications, including skin
rejuvenation, treatments for wrinkles, discoloration and tissue
tightening as a result of tissue coagulation. The Apogee Elite
family of products is a comprehensive hair removal system that
allows aestheticians to treat clients of all skin types. The system
also may be used for treatment of facial and leg veins, as well as
benign epidermal pigmented lesions. "We are excited about the
opportunity to partner with Depilite to bring the Affirm and Apogee
Elite to these dynamic and fast-growing markets," said Cynosure
President and Chief Executive Officer Michael R. Davin. "In
addition to its existing centers, Depilite has informed us that it
plans to expand to 150 locations within the next year in ten
countries and we welcome the potential to expand our relationship
with Depilite as they continue to grow. Beyond its own centers,
Depilite plans to sell and service our products in these five
countries, further expanding our geographic footprint and
reinforcing the strength of the Cynosure brand." "This agreement
represents an opportunity to provide our customers with leading
anti-aging and hair-removal products," commented Lalo Martinez,
President of Depilite. "But above that, Cynosure's unique approach
to customer support is a compelling benefit for the owners and
operators within the Depilite franchise. We are also excited to
expand our current business model and begin to distribute Cynosure
products outside our existing network within the territory." About
Cynosure, Inc. Cynosure, Inc. develops and markets aesthetic
treatment systems that are used by physicians and other
practitioners to perform non-invasive and minimally invasive
procedures to remove hair, treat vascular lesions, rejuvenate skin
through the treatment of shallow vascular and pigmented lesions,
laser lipolysis and temporarily reduce the appearance of cellulite.
Cynosure's products include a broad range of laser and other
light-based energy sources, including Alexandrite, pulsed dye,
Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure
was founded in 1991. About Depilite Medic Spa Depilite is an
international company that operates within the beauty industry. The
company provides non-invasive aesthetic light based treatments for
permanent hair reduction complemented by further services such as
body sculpting and photo rejuvenation. The company was founded in
2002 and currently operates more than 100 branches located in seven
countries in North America, Europe and Latin America. For corporate
or product information, contact Cynosure at 800-886-2966, or visit
http://www.cynosure.com/. Any statements in this press release
about future expectations, plans and prospects for Cynosure, Inc.,
including statements about Cynosure's agreement with Depilite Medic
Spa Equipment Corp, future sales of Cynosure products by Depilite
Medic Spa Equipment Corp, the markets in which Cynosure's products
are sold and other statements containing the words "believes,"
"anticipates," "plans," "expects," "will," and similar expressions,
constitute forward- looking statements within the meaning of The
Private Securities Litigation Reform Act of 1995. Actual results
may differ materially from those indicated by such forward-looking
statements as a result of various important factors, including our
history of operating losses, our reliance on sole source suppliers,
competition in the aesthetic laser industry, economic, market,
technological and other factors discussed in Cynosure's Annual
Report on Form 10-K filed with the SEC. In addition, the
forward-looking statements included in this press release represent
Cynosure's views as of the date of this press release. Cynosure
anticipates that subsequent events and developments will cause its
views to change. However, while Cynosure may elect to update these
forward-looking statements at some point in the future, it
specifically disclaims any obligation to do so. These
forward-looking statements should not be relied upon as
representing Cynosure's views as of any date subsequent to the date
of this press release. DATASOURCE: Cynosure, Inc. CONTACT: Scott
Solomon, Vice President, Sharon Merrill Associates, Inc.,
+1-617-542-5300, or ; or Gretchen Bender of Greenough
Communications, , both for Cynosure, Inc. Web site:
http://www.cynosure.com/
Copyright
Cynosure (NASDAQ:CYNO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cynosure (NASDAQ:CYNO)
Historical Stock Chart
From Jul 2023 to Jul 2024